NCT03857425View on ClinicalTrials.gov

Helicobacter Pylori Eradication With Clostridum Butyricum Capsule and Bacillus Coagulans Tablets

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

August 31, 2019

Study Completion Date

September 15, 2019

Conditions
GastritisH Pylori InfectionDyspepsia
Interventions
DRUG

Clostridum Butyricum Capsule

Clostridum Butyricum Capsule 3\*420mg,twice daily for 8 weeks

DRUG

Bacillus Coagulans Tablets

Bacillus Coagulans Tablets 3\*350mg, three times daily for 8 weeks

DRUG

Clostridum Butyricum Capsule plus Bacillus Coagulans Tablets

Clostridum Butyricum Capsule 3\*420mg, twice daily for 8 weeks and Bacillus Coagulans Tablets 3\*350mg, three times daily for 8 weeks

Trial Locations (1)

710032

Xijing Hosipital of Digestive Disease, Xi'an

All Listed Sponsors
lead

Xijing Hospital of Digestive Diseases

OTHER

NCT03857425 - Helicobacter Pylori Eradication With Clostridum Butyricum Capsule and Bacillus Coagulans Tablets | Biotech Hunter | Biotech Hunter